Trials / Active Not Recruiting
Active Not RecruitingNCT03139305
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- AdventHealth Translational Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to examine the effect of prolonged (72 hour) administration of glucagon compared to placebo on energy expenditure in healthy, non-diabetic, obese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucagon | Low dose intravenous infusion for 72 hours at 12.5 ng/kg/min |
| DRUG | Glucagon | High dose intravenous infusion for 72 hours at 25 ng/kg/min |
| DRUG | Placebo | Intravenous infusion of saline for 72 hours |
Timeline
- Start date
- 2017-10-24
- Primary completion
- 2018-02-14
- Completion
- 2027-02-01
- First posted
- 2017-05-03
- Last updated
- 2026-03-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03139305. Inclusion in this directory is not an endorsement.